ETOSHIA JACKSON: Open Payments
NPI 1982248779 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$493 in 15 payments from 8 companies in 2025. Trend: 2023 $68 · 2024 $440 · 2025 $493
Food & beverage: $493
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 5 | $179 |
| Novo Nordisk Inc | 1 | $117 |
| Biogen, Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $42 |
| Dynavax Technologies Corporation | 2 | $39 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $17 |
Products named: DEXCOM G7 GSS (161), Ozempic, ZURZUVAE, Heplisav-B, Dexcom G6 Transmitter, TRELEGY ELLIPTA, ZEPBOUND, INJECTAFER.
Industry payments across TN — which companies pay providers there.
